Discovering and developing first-in-class medicines that address medical conditions prevalent in old age
Location: United States, California, Oakland
Employees: 11-50
Total raised: $70M
Founded date: 2021
Investors 2
| Date | Name | Website |
| 25.07.2023 | TCG Crosso... | tcgcrossov... |
| - | Atlas Vent... | atlasventu... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 01.09.2021 | Series A | $70M | Atlas Vent... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 29.03.2024 | A new Ozempic rival helps patients lose fat, but keep their ... | Health A new Ozempic rival helps patients lose fat, but keep their muscle — the holy grail for a wei... | businessin... |
| 14.07.2023 | Big Bucks For Obesity Treatments As Eli Lilly Buys Versanis ... | 1 Share Email Facebook Twitter LinkedIn Pharma giant Eli Lilly announced today that it is buying Ver... | news.crunc... |
| 01.09.2021 | Versanis Bio lands $70M | Versanis Bio has raised a $70 million Series A co-led by Atlas Venture and Medicxi. The Oakland, Cal... | pitchbook.... |
| 31.08.2021 | Versanis Bio : Announces $70 Million Series A Financing to A... | Versanis Bio today announced the closing of its Series A financing of $70 million to advance the cli... | marketscre... |
| 31.08.2021 | Versanis Bio Raises $70M in Series A Financing | Versanis Bio, an Oakland, Calif.-based company established to discover and develop first-in-class me... | finsmes.co... |
| - | Obesity drug maker Versanis to be bought by Eli Lilly for $1... | Eli Lilly will acquire Versanis, a privately held obesity drug maker, for up to $1.93 billion to exp... | cnbc.com/2... |